CSL logo

CSL Limited Stock Price

ASX:CSL Community·AU$58.3b Market Cap
  • 11 Narratives written by author
  • 0 Comments on narratives written by author
  • 553 Fair Values set on narratives written by author

CSL Share Price Performance

AU$121.81
-126.17 (-50.88%)
AU$140.00
Fair Value
AU$121.81
-126.17 (-50.88%)
13.0% undervalued intrinsic discount
AU$140.00
Fair Value
Price AU$121.81
AntonioS AU$140.00
danmad AU$143.15
AnalystConsensusTarget AU$138.19

CSL Community Narratives

Fair Value
·
Fair Value AU$140 13.0% undervalued intrinsic discount

CSL Investment Thesis

2users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
Fair Value
·
Fair Value AU$143.15 14.9% undervalued intrinsic discount

Strong buy. World-leading healthcare company with steady growth

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
·
Fair Value AU$138.19 11.9% undervalued intrinsic discount

CSL: Share Price Correction Will Present Opportunity As Vaccine Uncertainty Eases

2users have liked this narrative
0users have commented on this narrative
166users have followed this narrative
AU$143.15
14.9% undervalued intrinsic discount
Fair Value
Revenue
12% p.a.
Profit Margin
9.06%
Future PE
27.19x
Price in 2031
AU$205.47
CSL logo
CSL

CSL: The Dip Is the Opportunity

CSL: The Dip Is the Opportunity Most people look at CSL's stock chart right now and see a problem. Down 35% from its highs, margins cut in half, and a company in the middle of its biggest restructuring in decades.Read more

View narrative
AU$155
21.4% undervalued intrinsic discount
Fair Value
Revenue
8.71% p.a.
Profit Margin
9.06%
Future PE
34.43x
Price in 2031
AU$220.15
AU$132.9
8.3% undervalued intrinsic discount
Fair Value
Revenue
4.95% p.a.
Profit Margin
9.06%
Future PE
35.25x
Price in 2031
AU$188.4
AU$140
13.0% undervalued intrinsic discount
Fair Value
Revenue
15.13% p.a.
Profit Margin
9.06%
Future PE
24.14x
Price in 2031
AU$200.99
CSL logo
CSL

CSL will thrive with an 18% profit surge ahead

this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spam this is spamRead more

View narrative
AU$239.81
49.2% undervalued intrinsic discount
Fair Value
Revenue
6.48% p.a.
Profit Margin
18.04%
Future PE
28.04x
Price in 2030
AU$328.55
AU$138.19
11.9% undervalued intrinsic discount
Revenue
3.1% p.a.
Profit Margin
19.22%
Future PE
17.3x
Price in 2029
AU$170.78

Trending Discussion

Updated Narratives

CSL logo

Strong buy. World-leading healthcare company with steady growth

Fair Value: AU$143.15 14.9% undervalued intrinsic discount
5 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CSL logo

CSL Investment Thesis

Fair Value: AU$140 13.0% undervalued intrinsic discount
6 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CSL logo

CSL: The Dip Is the Opportunity

Fair Value: AU$155 21.4% undervalued intrinsic discount
23 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Adequate balance sheet average dividend payer.

4 Risks
2 Rewards

CSL Limited Key Details

US$15.4b

Revenue

US$7.4b

Cost of Revenue

US$8.0b

Gross Profit

US$6.6b

Other Expenses

US$1.4b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 18, 2026
2.91
51.87%
9.06%
46.7%
View Full Analysis

About CSL

Founded
1916
Employees
29904
CEO
Gordon Naylor
WebsiteView website
www.csl.com

CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Recent CSL News & Updates

New Narrative Jun 28

Strong buy. World-leading healthcare company with steady growth

CSL is one of Australia’s highest-quality businesses and has a long history of delivering strong returns. It is a global leader in plasma therapies, vaccines and biotechnology, with products that are difficult to replicate and protected by strict regulation.
Narrative Update Jun 25

CSL: Cost Cuts And Capacity Expansion Will Support Long Term Earnings Recovery

Analysts have trimmed their price target on CSL to about A$138 from roughly A$141. This reflects a slightly higher discount rate, modestly adjusted revenue growth and profit margin assumptions, and a lower future P/E multiple in their updated valuation work.

Recent updates

No updates